Related Experiment Videos
Serum beta 2-microglobulin and human immunodeficiency virus infection
J N Lacey1, M A Forbes, M A Waugh
1Department of Genito-urinary Medicine, General Infirmary at Leeds, UK.
AIDS (London, England)
|July 1, 1987
Summary
Serum beta 2-microglobulin (beta 2-M) is elevated in most HIV-infected individuals. Higher beta 2-M levels in HIV-positive men indicate immune dysfunction and predict progression to AIDS.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- Human Immunodeficiency Virus (HIV) infection leads to significant immune system impairment.
- Biomarkers are crucial for monitoring HIV disease progression and immune status.
Purpose of the Study:
- To investigate the association between serum beta 2-microglobulin (beta 2-M) levels and HIV infection.
- To determine if beta 2-M can serve as an indicator for immune dysfunction and disease progression in HIV-infected individuals.
Main Methods:
- Prospective evaluation of homosexual men in 1983 and 1985.
- Measurement of serum beta 2-microglobulin (beta 2-M) levels.
- Correlation of beta 2-M levels with HIV status, lymphocyte counts, and clinical manifestations like AIDS and ARC.
Main Results:
- Elevated serum beta 2-M was observed in 64% of HIV-infected men versus 6.7% of uninfected men.
- All patients with Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex (ARC) exhibited raised beta 2-M levels.
- Serum beta 2-M levels did not significantly differ between patients with persistent generalized lymphadenopathy (PGL) and asymptomatic HIV-infected patients.
- Serum beta 2-M levels above 3.0 mg/l in HIV-infected homosexual men were linked to progression to AIDS.
Conclusions:
- Raised serum beta 2-microglobulin (beta 2-M) is a significant indicator of immune dysfunction in HIV infection.
- Serum beta 2-M is a potential prognostic marker for the progression of HIV disease to AIDS.